We are live on
!
Find out more
BC
Blackhill Capital Portfolio holdings
AUM
$1.94B
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$685M
AUM Growth
+$52.8M
(+8.3%)
Cap. Flow
-$4.48M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
76.51%
Holding
68
New
1
Increased
7
Reduced
18
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$2.37M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.76M |
| 3 |
Merck
MRK
|
+$1.01M |
| 4 |
AbbVie
ABBV
|
+$863K |
| 5 |
Elanco Animal Health
ELAN
|
+$418K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.78M |
| 2 |
Williams-Sonoma
WSM
|
+$2.61M |
| 3 |
GE Aerospace
GE
|
+$1.79M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$623K |
| 5 |
Pfizer
PFE
|
+$405K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 43.61% |
| 2 | Healthcare | 34.49% |
| 3 | Communication Services | 5.12% |
| 4 | Energy | 4.72% |
| 5 | Technology | 4.69% |
Similar funds
FFH
OCM
AAA
FC
HC
NIM
CC
DCM
Blackhill Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Blackhill Capital held 68 positions worth $685M, up 8.3% from $633M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Blackhill Capital's Q4 2019 filing shows 1 new, 7 increased, 18 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 28,000 shares worth $84K. The largest sale was Celgene Corp, an estimated $2.78M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, down from 44% a quarter earlier, followed by Healthcare and Communication Services.
- Blackhill Capital's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 28,000 shares worth $84K.
- Blackhill Capital added most to Kinder Morgan in Q4 2019, an estimated $2.37M increase.
- Blackhill Capital's biggest Q4 2019 reduction was Williams-Sonoma, cutting an estimated $2.61M.
- Blackhill Capital fully exited Celgene Corp in Q4 2019, selling an estimated $2.78M.
- Blackhill Capital's ten largest holdings make up 77% of its $685M portfolio in Q4 2019.
- Blackhill Capital opened 1 new position and closed 5 in Q4 2019.
- Blackhill Capital's portfolio value rose 8.3% quarter-over-quarter to $685M.
Based on Blackhill Capital's 13F filing for Q4 2019, filed 10 Feb 2020.